When I eat, GLP-1 is released from my intestines, signaling the pancreas to produce insulin
10.3389/fimmu.2018.02997 100 ShiC
Genital tract infections, affecting approximately 10-15% of women and less frequently in men, are another potential adverse effect ( Skin infections, such as Fourniers gangrene, have been reported
GLP-1RAs: Beyond glycemic control GLP-1RAs such as semaglutide and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1RAs tirzepatide enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through central pathways
A: Everyone can benefit from an IV drip
Future research endeavors should encompass a comprehensive investigation spanning from preclinical studies to clinical trials